Evidence map›Paper›PMID 28329306›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Reply to Naktin.

Melanie Uhde, Mary Ajamian, Gary P Wormser, Adriana R Marques, Armin Alaedini

Abstract readLetterComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Melanie UhdeDepartment of Medicine, Columbia University Medical Center, New York, USA.
Mary AjamianDepartment of Medicine, Columbia University Medical Center, New York, USA.
Gary P WormserDivision of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, New York, USA.
Adriana R MarquesLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Armin AlaediniDepartment of Medicine, Columbia University Medical Center, New York, USA.

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
Assessment Of Patients With Borrelia InfectionZIAAI000695 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MARQUES, ADRIANA R · 2009 to 2025
$8.8M
Immunologic mechanisms in post-Lyme disease syndromeR56AI093763 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALAEDINI, ARMIN · 2011 to 2011
$360k
NIAID NIH HHS R56 AI093763NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

C-Reactive ProteinSerum Amyloid A ProteinDiagnostic Tests, RoutineHumansLyme DiseaseC-Reactive ProteinSerum Amyloid A Protein

Identifiers

PMID28329306
PMCPMC5848335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.